ARTICLE | Company News
AstraZeneca, Osaka University deal
October 6, 2008 7:00 AM UTC
BIKEN, the university's research foundation for microbial disease, received non-exclusive rights from AstraZeneca's MedImmune Inc. subsidiary to use reverse genetics technology to develop influenza va...